U.S. markets open in 3 hours 44 minutes

  • S&P Futures

    4,080.75
    +10.75 (+0.26%)
     

  • Dow Futures

    33,335.00
    +7.00 (+0.02%)
     

  • Nasdaq Futures

    13,693.75
    +89.00 (+0.65%)
     

  • Russell 2000 Futures

    2,236.00
    +16.80 (+0.76%)
     

  • Crude Oil

    59.41
    -0.36 (-0.60%)
     

  • Gold

    1,743.70
    +2.10 (+0.12%)
     

  • Silver

    25.29
    +0.04 (+0.17%)
     

  • EUR/USD

    1.1875
    +0.0001 (+0.01%)
     

  • 10-Yr Bond

    1.6530
    0.0000 (0.00%)
     

  • Vix

    17.03
    -1.09 (-6.02%)
     

  • GBP/USD

    1.3741
    +0.0003 (+0.02%)
     

  • USD/JPY

    109.5650
    -0.2650 (-0.24%)
     

  • BTC-USD

    56,923.48
    -821.54 (-1.42%)
     

  • CMC Crypto 200

    1,197.15
    -29.62 (-2.41%)
     

  • FTSE 100

    6,894.70
    +9.38 (+0.14%)
     

  • Nikkei 225

    29,708.98
    -21.81 (-0.07%)
     

Opportunities in the Global Active Pharmaceutical Ingredients (API) Market - Global API Market to Reach $313 Billion by 2027

Research and Markets
·4 min read

Dublin, April 08, 2021 (GLOBE NEWSWIRE) -- The "Global Active Pharmaceutical Ingredients (API) Market 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

The global active pharmaceutical ingredients (API) market will reach $313.6 billion by 2027, growing by a revised 2020-2027 CAGR of 7.1% owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.

This report is based on a comprehensive research of the entire global API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2020 and provides forecast from 2021 till 2027 with 2020 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure

  • Growth Drivers

  • Restraints and Challenges

  • Emerging Product Trends & Market Opportunities

  • Porter's Five Forces

Based on Manufacturing Process, the global market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.

Captive Manufacturing

  • Branded Captive API

  • Generic Captive API

Merchant Manufacturing by Drug Type:

  • Branded Merchant API

  • Generic Merchant API

Merchant Manufacturing by Drug Synthesis:

  • Merchant Synthetic API

  • Merchant Biotech API

Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.

  • Infectious Diseases

  • Oncology

  • Ophthalmology

  • Cardiovascular Disorders

  • Central Nervous System

  • Pulmonary Disorders

  • Orthopedics

  • Other Applications

Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.

  • Branded Prescription Drugs

  • Generic Prescription Drugs

  • OTC Drugs

Geographically, the following regions together with the listed national/local markets are fully investigated:

  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

  • North America (U.S., Canada, and Mexico)

  • South America (Brazil, Chile, Argentina, Rest of South America)

  • RoW (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter's Five Forces Analysis

3 Segmentation of Global Market by Synthesis

4 Segmentation of Global Market by Manufacturing Process

5 Segmentation of Global Market by Therapeutic Application

6 Segmentation of Global Market by Drug Type

7 Segmentation of Global Market by Region

8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles

  • AbbVie Inc.

  • Astrazeneca

  • Aurobindo Pharma Ltd.

  • BASF

  • Bayer AG

  • Boehringer Ingelheim

  • Dr. Reddy's Laboratories

  • F. Hoffmann-La Roche

  • GlaxoSmithKline plc

  • Lonza Group

  • Lupin Limited

  • Merck & Co., Inc.

  • Mylan NV

  • Novartis International AG

  • Pfizer Inc.

  • Sanofi

  • Sun Pharmaceutical Industries Ltd.

  • Teva Pharmaceutical Industries Ltd.

9 Investing in Global Market: Risk Assessment and Management
9.1 Risk Evaluation of Global Market
9.2 Critical Success Factors (CSFs)


For more information about this report visit https://www.researchandmarkets.com/r/t58a39

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Recommended Stories

  • ‘Vaccine Euphoria’ Is Over for Pound Bulls as Rollout Hits Snags

    (Bloomberg) -- Pound bulls betting on the U.K.’s superior vaccine rollout are getting cold feet, threatening one of the hottest currency trades of the year.The euro recorded its biggest jump against sterling in 2021 on Tuesday, and extended gains above 86 pence on Wednesday. Traders have been selling the pound on concerns relating to AstraZeneca Plc’s shot -- which the U.K. is heavily dependent on -- while the shared currency has been buoyed by projections the bloc will hit immunization targets earlier than expected.It comes after months of the U.K. currency outpacing that of its nearest neighbor, racking up multi-year records as traders bet Britain’s rapid inoculation program would leave the European Union in the dust.Now, investors risk getting left on the wrong side of the trade with leveraged funds’ long sterling bets close to their highest in a year, according to data from the Commodity Futures Trading Commission. Hedge funds closed bullish pound positions on Wednesday.“We are observing a reversal of the vaccination euphoria,” said Petr Krpata, a strategist at ING Groep NV. “It is also exaggerated by speculative positioning, with the pound being the biggest speculative long in the G-10 FX space.”After Brexit trade discussions were sealed at the end of last year, the focus for pound traders pivoted to the U.K.’s vaccine rollout, which quickly established a lead over the EU. Britain has given around three times as many doses as a proportion of its population compared to the EU, according to Bloomberg’s vaccine tracker, with the bloc’s effort being curtailed by disputes and delays.Now, the U.K. campaign is hitting new snags. Vaccination centers and pharmacies are facing a “significant reduction” in supply of doses during April, meaning that older people waiting for second doses will be prioritized over younger people getting their first shot.Meanwhile, U.K. medical regulators advised that under-30s should not receive the AstraZeneca vaccine in a “course correction” to the country’s rollout plan. The pound dropped on Wednesday as shorts in the euro-sterling pair were unwound, according to a Europe-based trader.“It looks like many positives are in the price of the pound by now and the currency is looking overvalued and overbought, especially versus the euro,” said Valentin Marinov, head of G-10 currency research at Credit Agricole in London. “Sterling is no longer the vaccine champion of G-10 and, more broadly, the slowing pace of the Covid vaccinations in the U.K. could ultimately delay the government’s plans to reopen the economy.”To be sure, April is historically a supportive month for the pound, driven in part by the new U.K. tax year and corporate dividend repatriation of overseas income. The U.K. government, meanwhile, is insisting it’s on track to reach its target of vaccinating all adults by the end of July. It began giving out Moderna Inc. shots on Wednesday.“Compared to the EU, the U.K. will emerge first from lockdown, gaining a head start in its economic recovery,” said Stuart Cole, chief macro strategist at Equiti Capital. “Indeed, in the U.K. the talk is very much of the potential strength of the recovery, while in the EU they are still working out how to distribute their pandemic recovery fund.”READ: EU Recovery Fund Outlook Faces Shadow of Doubt From S&P, PictetBut after finally breaking the 0.85 level against the euro last week, the pound hit its weakest level in a month on Wednesday as new vaccine headlines hit.“We are now very much at the stage where a lot of the good news on the vaccine front is now priced,” said Ned Rumpeltin, European head of foreign exchange strategy at Toronto-Dominion Bank. “This has left sterling exposed to risks of a correction against some of its main trading partners, just as some of the other major economies are starting to close the jab gap.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • USD/JPY Price Forecast – US Dollar Recovering

    The US dollar fell during Asian trading against the Japanese yen, but as the Europeans came back on board, the market started to recover again.

  • Market Wrap: Bitcoin Drops to Near $56K as Spot Trading Volume Remains Low

    The oldest cryptocurrency is looking at a price support level around $54,000, with resistance around $60,000.

  • Prosus nets $14.6 billion from sale of Tencent stake

    Amsterdam-based technology investor Prosus NV has netted $14.6 billion from the sale of a 2% stake in Tencent Holdings Ltd, the Chinese gaming and social media giant said, in one of the world's largest ever block trades. "Our belief in Tencent and its management team is steadfast, but we also need to fund continued growth in our core business lines and emerging sectors," Prosus Chairman Koos Bekker said in a statement after the completion of the deal on Thursday. In a Hong Kong Stock Exchange filing, Tencent said Prosus sold 191.89 million shares for HK$114.1 billion, reducing its stake to 28.9%.

  • Credit Suisse can weather Archegos fallout, says IMF mission chief

    Credit Suisse should be able to weather a $4.7 billion loss from the Archegos hedge fund and the collapse of $10 billion worth of Greensill funds, with no meaningful risk to the Swiss financial sector's health from the episodes, the IMF's country mission head said. Shares in Credit Suisse have dropped by 25% in the space of a month, with Switzerland's second biggest bank reeling from its exposure to the collapse first of Greensill Capital and then Archegos Capital Management. "Our assessment is that the incidents are not systematic and they remain manageable by Credit Suisse," Mark Horton told reporters after the International Monetary Fund (IMF) published its report on Switzerland.

  • Uniqlo owner Fast Retailing lifts full-year profit outlook as China shines

    Japan's Fast Retailing, the owner of clothing brand Uniqlo, on Thursday reported a 23% jump in half-yearly operating profit and raised its full-year profit estimate, helped by a robust performance in China. The company has been among the most resilient retailers during the COVID-19 pandemic, as Uniqlo's focus on China and Japan helped it escape the worst of the downturn that hit the United States and Europe. "Sales and profits in China exceeded our projections," Chief Financial Officer Takeshi Okazaki told reporters in Tokyo.

  • Euro zone business activity returns to growth in March - PMI

    Euro zone business activity returned to growth last month, underpinned by a record expansion in the manufacturing sector, according to a survey on Wednesday that showed the service industry was coping with new lockdowns better than expected. As Europe battles a third wave of coronavirus infections, governments have re-imposed restrictions on citizens and forced swathes of the dominant services industry to remain closed. But IHS Markit's Services Purchasing Managers' Index (PMI) rose to 49.6 in March from February's 45.7, much higher than a flash estimate of 48.8 and only just shy of the 50 mark that separates growth from contraction.

  • BP Hit Its Debt Reduction Target a Year Early. Here’s What That Means for the Stock.

    BP stock climbed early on Tuesday, as the oil major said it would hit its net debt target almost a year earlier than expected, opening the door to share buybacks.

  • Iran’s Comeback To Oil Markets Unlikely To Cause Price Crash

    Iran’s possible return to a nuclear deal is unlikely to unleash a tidal wave of crude onto the markets as the country has been flouting U.S. sanctions and managed to keep its main customer well-supplied

  • Suez Agrees to $1.9 Billion Australian Sale to Cleanaway

    (Bloomberg) -- Suez SA agreed to sell its Australian business to Cleanaway Waste Management Ltd., with completion conditional on further talks about its own takeover by Veolia Environnement SA.Suez signed a deal to sell its recycling and recovery business in Australia to Melbourne-based Cleanaway for A$2.5 billion ($1.9 billion), the French water and waste-treatment firm said in a statement Tuesday. Under the terms, Suez can terminate the deal by May 6 if it gets taken over by Veolia, Cleanaway said in a filing.The arrangement leaves room for Suez to maneuver its own fate in its seven-month battle to convince shareholders that Veolia’s takeover offer is too low. Veolia bought almost 30% of Suez in October with a plan to absorb the whole company and create a new global leader in the sector.“We’re continuing to seek a friendly, negotiated solution with Veolia” with the aim of finding a solution by April 20, Suez Chairman Philippe Varin said on a conference call Tuesday. The valuation of the Suez asset sales, including in Australia, show that Veolia’s takeover offer, which it has resolutely maintained since October, “isn’t sufficient,” he said.Veolia said in a statement that Suez’s agreement to sell the Australian business creates another obstacle to a negotiated solution that will have a “negative impact” on its takeover offer. The company will continue to use “all legal means to prevent the sale of these strategic assets,” according to Veolia’s statement. Poison PillSuez on March 21 put forward a solution that would involve Veolia paying at least 20 euros ($23.63) per share -- 2 euros more than its offer -- and selling on over half of the company to Ardian SAS and Global Infrastructure Partners. It gave Veolia until April 20 to negotiate on that proposal.Alternatively, Suez wants a 22.50 euros per share bid by May 5, following which it would remove a so-called poison pill that’s meant to deter Veolia.Beyond that date, a legal mechanism has been put in place that would prevent any buyer from selling Suez’s French water assets until September 2024. It’s meant to complicate Veolia’s ability to resolve antitrust concerns after any deal unless it decides to sell its own French water business.Suez shares rose 0.3% in Paris trading, while Veolia was unchanged. Cleanaway surged 16% in Australia.The agreement with Cleanaway values Suez’s Australian assets at 12.9 times 2020 earnings before interest, taxes, depreciation and amortization, the company said. Given that Suez currently trades at about 8.5 times its Ebitda, the Australian deal shows the company is worth more than 20 euros a share, Chief Financial Officer Julian Waldron said.If no agreement is found with Veolia in the coming weeks, other asset sales can’t be ruled out, the Suez chairman said.Veolia or any other company can also make a higher bid for Suez’s Australian assets by April 21. If the deal between Suez and Cleanaway isn’t completed, the Australian utility will still acquire a portfolio of two landfills and five transfer stations in the Sydney region for A$501 million, the companies said.If the Australia deal is completed, it would make Cleanaway among the largest waste treatment operators in the country. It’s still currently searching for a new chief executive after longtime leader Vik Bansal announced plans to step down following an investigation into his workplace conduct.Cleanaway said it plans to raise new equity to partially fund the deal.(Updates with Veolia comment in fifth paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Nikola's fuel-cell development head exits, shares fall

    The departure comes just over a month after Nikola disclosed details on its hydrogen fuel-cell-powered product lineup that will include vehicles with a driving range of up to 900 miles. Schneider, who spent three years at the startup as an executive vice-president, oversaw the development of its fuel cell and hydrogen team, Nikola said in a statement. Nikola had publicly rejected all accusations.

  • Archegos: How Wall Street's hubris is a lesson for retail traders

    As Wall Street still clamors to untangle the levered Archegos bets on ViacomCBS and other stocks, lessons are emerging that ring true for both institutional and retail investors. However, while Wall Street lives on to trade another day, the retail crowd may not be as fortunate.

  • AUD/USD and NZD/USD Fundamental Daily Forecast – Buyers Tentative Ahead of Fed Minutes

    The conditions are ripe for a rally in the AUD/USD and NZD/USD, but buyers may be waiting for the release of the Fed minutes before making their move.

  • Top execs leave troubled refinery in U.S. Virgin Islands: letter

    The finance chief and two other top executives at Limetree Bay Ventures, operator of a long-stalled Caribbean oil refinery, are stepping down, according to an internal letter reviewed by Reuters. The 200,000-barrel-per-day refinery in St. Croix recently halted processing after a mishap, according to people familiar with the matter. It has run more than $1 billion over its original budget and well behind a plan to begin processing in late 2019.

  • Carousell Bets on Second-Hand Car Marketplace to Boost Revenue

    (Bloomberg) -- Carousell, a Southeast Asian online marketplace that lets people buy and sell second-hand goods, said it plans to invest aggressively to grow its classified cars business in the region.The Singapore-based startup, last valued at $850 million, will bolster its classified auto business across Malaysia, Vietnam, the Philippines, Hong Kong and Singapore with OneShift -- a portal that connects sellers with buyers and dealers -- and Reno Financial, which offers loans and other financial services, the company said in a statement.Carousell’s ambition underscores intensifying competition in the online second-hand car market in Southeast Asia, where middle class consumers are expected to swell in number to 334 million by 2030. Rivals Carsome, backed by investors including Asia Partners, and Carro, whose backers include Insignia Ventures Partners, both claim to be the region’s largest automotive marketplace and are trying to expand rapidly.“Covid has accelerated the trend of users buying and selling online, including for cars,” said Gaurav Bhasin, chief strategy officer of Carousell, who leads the firm’s automotive strategy. “We want to go one step further to power our autos brands with transactional models.”Carousell said it’s the most-visited auto classifieds platform in the region, with one of the biggest inventories of auto-related listings. Its cars business is now Carousell’s largest vertical, contributing a third of the company’s revenue.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Bitcoin Still Has Support From Long-Term Uptrend, Says Technical Analyst Katie Stockton

    Despite short-term volatility, bitcoin's uptrend remains intact. And some traders could be shifting to altcoins.

  • Amazon Reveals Scorching India Growth as Walmart Fight Deepens

    (Bloomberg) -- Amazon.com Inc. offered a rare peek into the Covid-era growth of its Indian business while it battles Walmart Inc. in its biggest overseas market.The U.S. online giant said it has enabled exports of Indian-made goods worth $3 billion and created over a million local jobs since it began operating in the Asian nation about a decade ago -- about $1 billion of that and 300,000 jobs since January 2020 alone. About 250,000 new sellers have joined Amazon.in since and more than 50,000 offline retailers and neighborhood stores are now on the platform, the company’s country chief said.The numbers illustrate the frenetic pace of growth in Indian online retail after the pandemic accelerated buying and selling in segments beyond smartphones and fashion. But Amazon has to contend with Walmart’s Flipkart and homegrown competitor Reliance Industries Ltd. in India, an increasingly important growth market since Amazon’s exit from China about a decade ago. American firms also face tightening regulations, antitrust scrutiny and accusations they’ve elbowed local players aside.Amazon India chief Amit Agarwal said the Seattle giant is on track to fulfill commitments made when founder Jeff Bezos visited the country in January 2020: to digitally enable 10 million businesses, handle e-commerce exports worth $10 billion and create 1 million additional jobs in India in the five years to 2025.Read more: Ambani Wages Price War With Amazon for $200 Billion India Prize“Covid-19 has made businesses realize they need to be more resilient, robust because there’s no notion of only offline or only online anymore,” Amazon India chief Amit Agarwal said in a phone interview on Thursday to discuss the unit’s progress. “The internet is like electricity, everybody will use it.”Bezos has made India the centerpiece of his global ambitions, a burgeoning market for not just online goods but also video content and gadgets. The country, one of the last big consumer markets still up for grabs, will generate $200 billion in e-commerce sales by 2026, Morgan Stanley estimates.It’s also a source of talent. Amazon has hired locally in fields like machine learning and software development, while employing an army to staff its giant fulfillment centers. It’s also profiting by helping more than 70,000 Indian exporters sell everything from toys and bed linen to jewelry and tea to 300 million customers across 200 countries.Read more: Walmart’s Flipkart Is Said to Aim for IPO in Fourth QuarterReliance and Flipkart, which is said to be preparing for a fourth-quarter initial public offering, are employing the same playbook but Agarwal said Indian e-commerce remains embryonic and can support several major players.Amazon will focus on local execution while complying with local regulations as they evolve, he added. The Ministry of Commerce and Ministry of Information Technology have been pondering a raft of laws and rule changes to protect consumer data and eradicate anticompetitive practices, while a backlash against U.S. and Chinese internet giants grows. Agarwal said Amazon is compliant but stressed a stable regulatory system -- particularly during a time of heightened global uncertainty -- was essential to drawing more investment into India.“We are more than happy to be inspected, our job is to focus on the customer and India is a long term investment for Amazon,” he said. He said it’s not the time to make changes. “Changes are very disruptive and any rule changes require adherence and changes on our part.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Swedish Central Bank Reveals First Study of Digital Currency

    (Bloomberg) -- The Swedes are learning that their once pioneering vision for a central bank digital currency might take a lot longer to enact than initially thought.The Riksbank just published the results of the first phase of a pilot project into what is essentially the most advanced exploration of a post-cash era to be undertaken by a major, western economy. It says the rapid pace at which cash is disappearing presents “potential problems” that a digital currency controlled by a central bank can address.The task is huge and Sweden’s central bank, the world’s oldest, keeps pushing back its timeline. After once suggesting it might be ready to move ahead with an e-krona by 2018, the Riksbank now says the current pilot project won’t be completed until early next year, and has even given itself room to continue trying until the end of 2026.Other central bankers have openly dismissed the notion that there’s any reward to be gained from being a first-mover in the field of digital currencies. Federal Reserve Chairman Jerome Powell recently said the U.S. would rather be right than first.“In most economies it will take time. And especially if lawmakers need to weigh in,” Johanna Jeansson of Bloomberg Economics.GLOBAL INSIGHT: Carpe Diem - Central Banks in Digital Future Mithra Sundberg, who heads the Riksbank unit that’s running the project from Stockholm, suggests it’s important not to settle on the technology before figuring out exactly what the digital currency needs to do. That’s as the Riksbank makes clear it’s not replacing cash, and that whatever it ends up creating -- if it moves ahead -- will probably require a new legal framework before it can be used.Meanwhile, cash in the form of bank notes and coins is slowly but surely petering out in the largest Nordic economy. Last year, Swedes used cash less often than the citizens of seven other “mature” markets, as a percentage of total transactions, according to the McKinsey Global Payments Report.But not everyone sees cashlessness as a trigger for embarking on a digital currency project. In neighboring Norway, another virtually cashless society, the central bank says there’s “no acute need” to introduce a digital currency.What Bloomberg Economics Says...“The motivation for introducing a central bank digital currency may change as policy makers explore the issue. Simply introducing a complement to cash for retail transactions may not make much of a difference in the economy. Using wholesale CBDCs in cross-border transactions has the potential to raise efficiency. Employing new digital tools for policy purposes could really alter the macroeconomic playing field. The bigger the step, the more thought it’s likely to require. Expect that to take time.”-- Johanna Jeansson, Scandinavia economistSundberg says Sweden’s e-krona pilot project hasn’t yet explored the monetary policy ramifications of such a transformation. But she and her team have “looked at the technical possibilities of being able to charge interest,” she says.The Riksbank’s pilot project shows that it would be possible to apply interest rates on a CBDC, regardless of whether it’s account-based or token based. If a negative interest rate is to be applied, the end-user can hold the tokens, but not a separate key that provides access to those tokens.“The compatibility of an interest-bearing ekrona, positive or negative, with a distribution model as tested in phase one, is a much broader question than the purely technical possibilities and limitations,” the Riksbank said.For now, the Riksbank is focusing on a so-called two-tier model, in which it would be responsible for the issuance and redemption of a CBDC. In such a framework the so-called participants, such as banks or payment firms, would have direct contact with the end-user, according to Micael Lindgren, the technical project manager at the Riksbank.Ultimately, politicians and not central bankers will decide what the future of money will look like in Sweden. Lawmakers will judge whether the information produced through the pilot project persuades them that an e-krona is even necessary, and if so, what form it should take.(Adds comment from Bloomberg Economics)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Asia shares trudge behind as S&P futures scale new peak

    Asian share markets lagged behind on Thursday as U.S. stock futures hit new peaks after the Federal Reserve underlined its commitment to keeping policy super loose even as the economy enjoys a rapid recovery. MSCI's broadest index of Asia-Pacific shares outside Japan inched up 0.2% in very quiet trade. Japan's Nikkei slipped 0.3%, not helped by news Tokyo's governor had asked for emergency measures to stem a surge of COVID-19 infections.

  • XRP surges above $1 for first time since 2018

    Ripple’s XRP token has vastly benefitted from what some are describing as a weekend “alt season”, with it rising above the psychological level of resistance at $1.00.